Skip to main content
TipRanks
Go Ultimate75% OFF

Stephen G Davies Insider Profile

4 Followers

Stephen G Davies, former Director at Summit Therapeutics, holds 8.16M shares in Summit Therapeutics (Ticker: GB:SUMM). Most recently, Stephen G Davies Bought 500,000 shares of Summit Therapeutics on Apr 05, 2012 for an estimated value of 15.00K .

Stephen G Davies's Trading History

SUMM
Summit Therapeutics
Apr 05, 2012―Informative Buy15.00K£3.06M
GB:SUMM
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Apr 05, 2012Informative Buy£15.00K500,000£3.00――
Mar 05, 2010Informative Buy£2.35K50,000£5.00――
Mar 05, 2010Informative Buy£50.00K1,000,000£5.00――
Nov 02, 2009Informative Buy£5.50K100,000£6.00――
Oct 30, 2009Informative Buy£16.35K300,000£5.00――

You May Also Like

Stephen G Davies insider profile FAQ

What is the percentage of profitable transactions made by Stephen G Davies?
The percentage of profitable transactions made by Stephen G Davies is 20%.
What is the average return per transaction made by Stephen G Davies?
The average return per transaction made by Stephen G Davies is -30.80%.
What stocks does Stephen G Davies hold?
Stephen G Davies holds: GB:SUMM stocks.
What was Stephen G Davies’s latest transaction?
Stephen G Davies’s latest transaction was an Informative Buy of 15.00K .
What is Stephen G Davies's role in Summit Therapeutics?
Stephen G Davies's role in Summit Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.